Patents for C12R 1 - Micro-organisms (92,025)
01/2002
01/22/2002US6340592 Human cell lines
01/22/2002US6340586 Strain of the microorganism penicillium oxalicum var. armeniaca and its application
01/22/2002US6340585 Synthetic medium for cultivating Lactobacillus and Bifidobacteria
01/22/2002US6340582 Reacting gluconobacter oxydans or acetobacter xylinum with d-arabitol to produce xylitol; where the microorgansims can metabolize carbon sources; for use in low caloric sweeteners, anticarcinogenic agents and therapy for diabetes
01/22/2002US6340579 Gene encoding an alpha-hydroxy-gamma-carboxymuconic acid-epsilon-semialdehyde dehydrogenase
01/22/2002US6340577 Protein fragments for use in protein targeting
01/22/2002US6340574 Regulated autocrine growth of mammalian cells
01/22/2002CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells
01/22/2002CA2149333C Eck receptor ligands
01/22/2002CA2057711C Antibiotic agent
01/22/2002CA2038398C Dna encoding a growth factor specific for epithelial cells
01/22/2002CA1341333C Amylin peptides and uses thereof
01/18/2002CA2349743A1 Diagnostic assay
01/17/2002WO2001054672A3 Closure of bacterial ghosts
01/17/2002WO2001053474A3 Flavobacterium heparinum expression system
01/17/2002WO2001049838A3 Cis-acting regulatory nucleic acid sequences in the parathyroid hormone 3'-untranslated region
01/17/2002WO2001032838A3 Methods for improving viral vector titers and reducing cell death in cell cultures
01/17/2002WO2001032830A3 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
01/17/2002WO2001030997A3 Microbe, microbial exopolysaccharide, and uses thereof
01/17/2002WO2001030996A3 Microbial exopolysaccharide and uses thereof
01/17/2002WO2001016308A3 Plant sterol acyltransferases
01/17/2002WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF
01/17/2002WO2000078971A3 Atp binding cassette transporter protein abc1 popypeptides
01/17/2002US20020006651 To convert ethyl 4-chloroacetoacetate using NADPH as a coenzyme to produce ethyl (S)-4-chloro-3-hydroxybutyrate; substrate specificity, no activity to ethyl acetoacetate, specified optimal pH and temperature; enzyme from candida
01/17/2002US20020006450 Improved physical properties and shelf life, in the form of powdered clathrates in which Aureobacidium culture solution as a guest is included in cyclodextrin as a host component
01/17/2002US20020006432 Bifidobacterium in the treatment of inflammatory disease
01/17/2002US20020006407 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
01/17/2002US20020006391 Genetic engineering
01/17/2002DE10032058A1 Mikrobielle Produktion von R-Phenylacetylcarbinol durch biologische Umwandlung von Benzaldehyd durch filamentöse Pilze Microbial production of R-phenylacetylcarbinol by biotransformation of benzaldehyde by filamentous fungi
01/17/2002CA2351110A1 Helicobacter felis vaccine
01/16/2002EP1172441A1 A promoter derived from phytosulfokine precursor gene
01/16/2002EP1172438A1 Polyhyroxyalkanoate synthase and gene encoding the same enzyme
01/16/2002EP1172434A1 Purple photosynthetic bacteria and health foods
01/16/2002EP1171631A1 Assay for detecting phospho-n-acetylmuramyl-pentapeptide translocase activity
01/16/2002EP1171624A1 Method and means for producing high titer, safe, recombinant lentivirus vectors
01/16/2002EP1171623A2 Production of attenuated negative stranded rna virus vaccines
01/16/2002EP1171620A1 Acquired resistance genes in plants
01/16/2002EP1171615A2 Cell culture process for glycoproteins
01/16/2002EP1171608A2 Recombinant and mutant marek's disease virus
01/16/2002EP1171595A1 13 transmembrane protein expressed in prostate cancer
01/16/2002EP1171591A1 48 human secreted proteins
01/16/2002EP1171579A1 Human tumor necrosis factor receptor tr9
01/16/2002EP1171578A2 Pharmaceutical composition comprising pim-activated nkt cells, and therapeutic use thereof
01/16/2002EP1171576A1 PSEUDOMYCIN PRODUCTION BY $i(PSEUDOMONAS SYRINGAE)
01/16/2002EP1171574A1 Method for obtaining aspergillus niger cultures and their uses for producing ferulic acid and vanillic acid
01/16/2002EP1171469A1 ANTI-p53 ANTIBODIES
01/16/2002EP1171457A1 46 human secreted proteins
01/16/2002EP1171000A1 Novel protective cultures and use thereof for preserving foodstuffs
01/16/2002EP0840791B1 Generation of immune responses to prostate-specific antigen (psa)
01/16/2002EP0811071B1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
01/16/2002EP0743986B1 Heterologous dimeric proteins produced in heterokaryons
01/16/2002EP0697875B1 Use of modified tall-104 cells to treat cancer and viral diseases
01/16/2002EP0515516B1 Methods for identifying heterofunctional fusion proteins
01/16/2002EP0496875B1 METHODS FOR PRODUCING RNA VIRUSES FROM cDNA
01/16/2002CN1331753A Essential genes from C albicans and method for screening antimycotic substances using said genes
01/16/2002CN1331751A Improved i(in vivo) prodn. of cephalosporins
01/16/2002CN1331750A Prodn. of ascorbic acid using yeast
01/16/2002CN1331749A Method for producing ascorbic acid intermediates
01/16/2002CN1331743A Method for producing chiral carboxylic acids from nitriles with assistance of nitrilase or microorganisms which contain gene for nitrilase
01/16/2002CN1331701A Modified peptides as therapeutic agents
01/16/2002CN1331700A Generation of antibodies using polynucleotide vaccination in avian species
01/16/2002CN1331250A Glucoprotein having inhibitory activity to pyroric spirillar colonization
01/16/2002CN1077767C Compsns. contg. vesicular-arbuscular mycorrhizal fungi and its culture method
01/15/2002US6339070 Gene directed enzyme prodrug therapy (gdept) using in situ antibody generation to provide enhanced selectivity, in cancer therapy; for delivering cytotoxic drugs
01/15/2002US6339061 Process for the stabilization of proteins in complex mixtures during their storage in aqueous solvents
01/15/2002US6338959 An isolated dna; for increased production of alpha-amylase and pullulanase for improved dish washing detergent and laundry detergent
01/15/2002US6338957 Method for producing halo-L-tryptophan
01/15/2002CA2191197C Method and means for the production of hyaluronic acid
01/15/2002CA2082259C Enzyme capable of degrading cellulose or hemicellulose
01/15/2002CA2077347C Cloning vectors and/or expression, their preparation process and their use
01/15/2002CA2036894C Vectors and compounds for expression of glycosylation mutants of human protein c
01/15/2002CA2001719C Phosphorylated fusion proteins and uses related thereto
01/10/2002WO2002003069A1 cGMP-VISUALIZING PROBE AND METHOD OF DETECTING AND QUANTIFYING cGMP BY USING THE SAME
01/10/2002WO2002002811A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor
01/10/2002WO2002002791A1 Microbial production of r-phenylacetylcarbinol by biotransformation of benzaldehyde by filamentous fungi
01/10/2002WO2002002784A1 Regulated gene expression in yeast and methods of use
01/10/2002WO2002002749A1 Transformed yeast for constructing combinatorial protein library
01/10/2002WO2002002748A1 Method for culturing micro-organisms in reducing conditions obtained by a gas stream
01/10/2002WO2002002591A2 Peptides for use in culture media
01/10/2002WO2002002138A1 Treating endotoxemia and related disorders with probiotics
01/10/2002WO2001085973A9 Antisense type gene trap vector
01/10/2002WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam)
01/10/2002WO2001042422A3 Acyl glucosaminyl inositol amidase family and methods of use
01/10/2002WO2001038358A3 Hbv/hcv virus-like particle
01/10/2002US20020004590 Acid phosphatase
01/10/2002US20020004589 Detecting sensitivity to kidney disease
01/10/2002US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6
01/10/2002US20020004243 Method for introducing recessive properties into the genetic background of industrial baker's yeast
01/10/2002US20020004229 Generating antibiotic; obtain vector, transform cell, express preferential enzyme in cells, recover antibiotic
01/10/2002US20020004040 Complementary adenoviral vector systems and cell lines
01/10/2002DE10031236A1 Verwendung von Carbonsäuren und anderen Additiven in Kombination mit kationischen Verbindungen zur Stabilisierung von Nukleinsäuren in biologischen Materialien Use of carboxylic acids and other additives in combination with cationic compounds to stabilize the nucleic acids in biological materials
01/10/2002CA2414742A1 Microbial production of r-phenylacetylcarbinol by biotransformation of benzaldehyde by filamentous fungi
01/10/2002CA2412946A1 Method for controlling the microbiological quality of an aqueous medium and kit therefor
01/10/2002CA2408829A1 Regulated gene expression in yeast and methods of use
01/09/2002EP1170383A2 Oligonucleotides and method for detection of small round structured virus (SRSV) RNA
01/09/2002EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
01/09/2002EP1170376A1 Method for producing substances utilizing microorganisms
01/09/2002EP1170369A1 Extracellular protease from acremonium chrysogenum with cpc-acetyl hydrolase activity and its utilization in the synthesis of deacetylated derivatives of cephalosporin c and inactivation of the gene for increasing production of cephalosporin
01/09/2002EP1170368A2 Immunization by inoculation of dna transcription unit
01/09/2002EP1170361A2 New mutant N-Acetylglutamate synthase and method for L-Arginine production